Cell-based therapies for Parkinson's disease.
1Cambridge University Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. scd39@cam.ac.uk
Expert Review of Neurotherapeutics
|June 10, 2011
Summary
Parkinson's disease (PD) involves motor and non-motor symptoms due to dopamine neuron loss. Cell transplantation offers a potential reparative therapy, driving research into optimal dopaminergic neuron sources.
Area of Science:
- Neuroscience
- Regenerative Medicine
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder characterized by motor symptoms like bradykinesia, rigidity, and tremor.
- Pathology involves dopaminergic neuron degeneration in the substantia nigra, leading to reduced dopamine in the striatum.
- PD also presents significant non-motor features and non-nigral pathology.
Purpose of the Study:
- To review the historical development of dopaminergic cell transplantation for Parkinson's disease.
- To explore various sources for transplantable dopaminergic neurons.
- To discuss the ongoing search for a sustainable and effective cell source for PD therapy.
Main Methods:
- Review of existing literature on Parkinson's disease and cell transplantation.
- Analysis of different cell sources, including fetal tissue, somatic cells, embryonic stem cells, and induced pluripotent stem cells.
- Evaluation of the potential of these sources for generating dopaminergic neurons for transplantation.
Main Results:
- Dopaminergic cell transplantation is a promising therapeutic strategy for Parkinson's disease.
- Multiple cell sources are being investigated, each with unique advantages and challenges.
- The field is actively seeking a reliable, long-term source of transplantable dopaminergic neurons.
Conclusions:
- Cellular transplantation holds significant potential for treating Parkinson's disease.
- Continued research into diverse cell sources is crucial for advancing this therapy.
- Identifying an optimal, sustainable source of dopaminergic neurons is key to successful clinical application.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...